Fermented beetroot modulates gut microbial carbohydrate metabolism in prediabetes and prevents high-fat diet induced hyperglycemia in a prediabetic model

Lists

Banan-Mwine Daliri, Eric, Ashwinipriyadarshini, Megur, Mingaila, Jonas, Kumar Vijaya, Akshay, Balnionyte, Toma, Sakar, Debalina, Carnicero-Mayo, Yaiza, Behrends, Volker ORCID: https://orcid.org/0000-0003-4855-5497, Costabile, Adele and Burokas, Aurelijus (2025) Fermented beetroot modulates gut microbial carbohydrate metabolism in prediabetes and prevents high-fat diet induced hyperglycemia in a prediabetic model. Current Research in Food Science, 10. pp. 1-11.

Preview

PDF (PDF/A)
Fermented beetroot modulates gut microbial carbohydrate metabolism in_accessible.pdf - Draft Version
Available under License Creative Commons Attribution Non-commercial.
Download (7MB) | Preview

Official URL: https://www.sciencedirect.com/science/article/pii/...

Abstract

The global increase in prevalence of (pre-)diabetes demands immediate intervention strategies. In our earlier work, we demonstrated in vitro antidiabetic potential of a fermented beetroot product (PN39). Here, we examined the impact of PN39 on glucose tolerance and gut microbiota in C57BL/6J male mice and on prediabetic (PD) subjects’ stool microbiota. In mice, high-fat diet (HFD) consumption for 9 weeks resulted in hyperglycemia and impaired glucose tolerance (GT) while concomitant consumption of PN39 and HFD (PN39+HFD) prevented GT impairment. Meanwhile, feeding the mice with HFD for 5 weeks to induce PD and later administering them with PN39 for 4 weeks (PD + PN39) neither improved fasting blood glucose nor GT. Relative to control groups, the gut microbiota of both PD mice and humans were characterized by decreased Clostridia UCG-014 and Lactobacilli as well as significantly altered gut microbial carbohydrate metabolism. Feeding PN39 together with HFD preserved Clostridia UCG-014 and Lactobacilli, increased short chain fatty acid production relative to mice fed with HFD only. Treating gut microbiota of PD subjects with PN39 however increased Clostridia UCG-014 and Lactobacilli populations and increased short chain fatty acids concentrations in the stools. In both mice and humans, PN39 treatment rectified the altered microbial carbohydrate metabolism observed in their PD counterparts. This suggests that the gut microbial modulatory effects of PN39 coupled with its capacity to regulate gut microbial glucose metabolism, likely played a role in preventing PD in mice receiving PN39+HFD. Taken together, our results indicate that PN39 could act as a potent antidiabetic functional food for preventing diabetes and its associated dysbiosis.

Item Type:	Article
Identifier:	10.1016/j.crfs.2025.101052
Keywords:	Hyperglycemia, Functional food, Gut microbiota, Dysbiosis, Gut microbial metabolism
Subjects:	Medicine and health > Microbiology
Depositing User:	Volker Behrends
Date Deposited:	25 Apr 2025 08:22
Last Modified:	25 Apr 2025 08:30
URI:	https://repository.uwl.ac.uk/id/eprint/13498

Downloads

Downloads per month over past year

Actions (login required)

View Item

References

American Diabetes Association, 2020. Classification and diagnosis of diabetes: standards of medical care in diabetes—2020. Diabetes Care 43, S14–S31. https://doi.org/ 10.2337/dc20-S002.

Bajaj, S., Rekwal, L., Misra, S., Misra, V., Yadav, R.K., Srivastava, A., 2014. Association of Helicobacter pylori infection with type 2 diabetes. Indian Journal of Endocrinology and Metabolism 18 (5), 694–699. https://doi.org/10.4103/2230-8210.139235.

Behrends, V., Tredwell, G.D., Bundy, J.G., 2011. A software complement to AMDIS for processing GC-MS metabolomic data. Anal. Biochem. 415 (2), 206–208. https://doi. org/10.1016/j.ab.2011.04.009.

Beresford-Jones, B.S., Forster, S.C., Stares, M.D., Notley, G., Viciani, E., Browne, H.P., Boehmler, D.J., Soderholm, A.T., Kumar, N., Vervier, K., 2022. The mouse gastrointestinal bacteria catalogue enables translation between the mouse and human gut microbiotas via functional mapping. Cell Host Microbe 30 (1), 124–138e128. https://doi.org/10.1016/j.chom.2021.12.003.

Burokas, A., Martín-García, E., Espinosa-Carrasco, J., Erb, I., McDonald, J., Notredame, C., Dierssen, M., Maldonado, R., 2018. Extinction and reinstatement of an operant responding maintained by food in different models of obesity. Addict. Biol. 23 (2), 544–555. https://doi.org/10.1111/adb.12597.

Chamata, Y., Watson, K.A., Jauregi, P., 2020. Whey-derived peptides interactions with ACE by molecular docking as a potential predictive tool of natural ACE inhibitors. Intrnational Journal of Molecular Sciences 21 (3), 864. https://doi.org/10.3390/ ijms21030864.

Chen, L.W., Chien, C.Y., Yang, K.J., Kuo, S.F., Chen, C.H., Chien, R.N., 2015. Helicobacter pylori infection increases insulin resistance and metabolic syndrome in residents younger than 50 years old: a community-based study. PLoS One 10 (5), e0128671. https://doi.org/10.1371/journal.pone.0128671.

Daliri, E.B.-M., Balnionyt˙ e, T., Stankeviˇci¯ut˙ e, J., Lastauskien˙ e, E., Meˇskys, R., Burokas, A., 2023a. High temperature lacto-fermentation improves antioxidant and antidiabetic potentials of Lithuanian red beetroot. LWT-Food Sci. Technol. 185, 115122. https://doi.org/10.1016/j.lwt.2023.115122.

Daliri, E.B.-M., Baltriukien˙ e, D., Burokas, A., 2023b. Beetroot for managing diabetes and its associated gut dysbiosis: current findings and challenges. Trends Food Sci. Technol. 142, 104216. https://doi.org/10.1016/j.tifs.2023.104216.

Demaria, T.M., Crepaldi, L.D., Costa-Bartuli, E., Branco, J.R., Zancan, P., Sola-Penna, M., 2023. Once a week consumption of Western diet over twelve weeks promotes sustained insulin resistance and non-alcoholic fat liver disease in C57BL/6 J mice. Sci. Rep. 13 (1), 3058. https://doi.org/10.1038/s41598-023-30254-2.

Diener, C., Reyes-Escogido, M.d.L., Jimenez-Ceja, L.M., Matus, M., Gomez-Navarro, C. M., Chu, N.D., Zhong, V., Tejero, M.E., Alm, E., Resendis-Antonio, O., 2021. Progressive shifts in the gut microbiome reflect prediabetes and diabetes development in a treatment-naive Mexican cohort. Front. Endocrinol. 11, 602326. https://doi.org/10.3389/fendo.2020.602326.

Draz, U., Rathore, R., Butt, N.F., Randhawa, F.A., Malik, U., Waseem, T., 2018. Presence of pre-diabetes in Helicobacter pylori positive versus Helicobacter pylori negative patients having dyspepsia. JPMA (J. Pak. Med. Assoc.) 68 (6), 939–941.

Echouffo-Tcheugui, J.B., Selvin, E., 2021. Prediabetes and what it means: the epidemiological evidence. Annu. Rev. Publ. Health 42, 59–77. https://doi.org/ 10.1146/annurev-publhealth-090419-102644.

Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., Krogh Pedersen, H., et al., 2015.

Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528 (7581), 262–266. https://doi.org/10.1038/nature15766.

Gerritsen, J., Dekker, J., TenVoorde, B., Bertelsmann, F., Kostense, P., Stehouwer, C., Heine, R., Nijpels, G., Heethaar, R., Bouter, L., 2000. Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study. Diabetologia 43, 561–570. https://doi.org/10.1007/s001250051344.

Gerstein, H.C., Santaguida, P., Raina, P., Morrison, K.M., Balion, C., Hunt, D., Yazdi, H., Booker, L., 2007. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Clinical Research 78 (3), 305–312. https://doi.org/ 10.1016/j.diabres.2007.05.004.

Guzior, D.V., Okros, M., Shivel, M., et al., 2024. Bile salt hydrolase acyltransferase activity expands bile acid diversity. Nature 626, 852–858. https://doi.org/10.1038/ s41586-024-07017-8.

Hsu, W.C., Lau, K.H.K., Matsumoto, M., Moghazy, D., Keenan, H., King, G.L., 2014. Improvement of insulin sensitivity by isoenergy high carbohydrate traditional Asian diet: a randomized controlled pilot feasibility study. PLoS One 9 (9), e106851. https://doi.org/10.1371/journal.pone.0106851.

Ingrosso, D.M.F., Primavera, M., Samvelyan, S., Tagi, V.M., Chiarelli, F., 2023. Stress and diabetes mellitus: pathogenetic mechanisms and clinical outcome. Horm. Res. Paediatr. 96 (1), 34–43. https://doi.org/10.1159/000522431.

Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergstr¨om, G., Behre, C.J., Fagerberg, B., Nielsen, J., B¨ackhed, F.J.N., 2013. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498 (7452), 99–103. https:// doi.org/10.1038/nature12198.

Kimura, I., Ozawa, K., Inoue, D., Imamura, T., Kimura, K., Maeda, T., Terasawa, K., Kashihara, D., Hirano, K., Tani, T., 2013. The gut microbiota suppresses insulin- mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4 (1), 1829. https://doi.org/10.1038/ncomms2852.

Liu, B., Popp, D., Müller, N., Str¨auber, H., Harms, H., Kleinsteuber, S.J.M., 2020. Three novel Clostridia isolates produce n-caproate and iso-butyrate from lactate: comparative genomics of chain-elongating bacteria. Microorganisms 8 (12), 1970. https://doi.org/10.3390/microorganisms8121970.

Lu, Y., Zhou, G., Ewald, J., Pang, Z., Shiri, T., Xia, J., 2023. MicrobiomeAnalyst 2.0: comprehensive statistical, functional and integrative analysis of microbiome data. Nucleic Acids Res. 51 (W1), W310–W318. https://doi.org/10.1093/nar/gkad407.

Lv, C., Pang, X., Sun, J., Li, X., Lu, Y., 2024. Screening of bile salt hydrolase-producing lactic acid bacteria and evaluation of cholesterol-lowering activity in vitro. Food Biosci. 62, 105338. https://doi.org/10.1016/j.fbio.2024.105338.

Matsuzawa-Nagata, N., Takamura, T., Ando, H., Nakamura, S., Kurita, S., Misu, H., Ota, T., Yokoyama, M., Honda, M., Miyamoto, K., 2008. Increased oxidative stress precedes the onset of high-fat diet–induced insulin resistance and obesity. Metabolism 57 (8), 1071–1077. https://doi.org/10.1016/j.metabol.2008.03.010.

Megur, A., Daliri, E.B.-M., Baltriukien˙e, D., Burokas, A.J., 2022. Prebiotics as a tool for the prevention and treatment of obesity and diabetes: classification and ability to modulate the gut microbiota. Int. J. Mol. Sci. 23 (11), 6097. https://doi.org/ 10.3390/ijms23116097.

Megur, A., Daliri, E.B.-M., Balnionyt˙e, T., Stankeviˇci¯ut˙e, J., Lastauskien˙e, E., Burokas, A., 2023. In vitro screening and characterization of lactic acid bacteria from Lithuanian fermented food with potential probiotic properties. Front. Microbiol. 14, 1213370. https://doi.org/10.3389/fmicb.2023.1213370.

Mei, Z., Wang, F., Bhosle, A., Dong, D., Mehta, R., Ghazi, A., Zhang, Y., Liu, Y., Rinott, E., Ma, S., Rimm, E.B., Daviglus, M., Willett, W.C., 2024. Strain-specific gut microbial signatures in type 2 diabetes identified in a cross-cohort analysis of 8,117 metagenomes. Nat. Med. 30, 2265–2276. https://doi.org/10.1038/s41591-024- 03067-7, 2024.

Obayiuwana, O.A., Behrends, V., Calle-Patino, Y., Barone, M., Turroni, S., Brigidi, P., Costabile, A., Corona, G.J., 2023. Cooking, Digestion, and in vitro colonic fermentation of Nigerian wholegrains affect phenolic acid metabolism and gut microbiota composition. Int. J. Mol. Sci. 24 (18), 14111. https://doi.org/10.3390/ ijms241814111.

Ofosu, F.K., Elahi, F., Daliri, E.B.-M., Aloo, S.O., Chelliah, R., Han, S.-I., Oh, D.-H., 2023. Fermented sorghum improves type 2 diabetes remission by modulating gut microbiota and their related metabolites in high fat diet-streptozotocin induced diabetic mice. J. Funct.Foods 107, 105666. https://doi.org/10.1016/j. jff.2023.105666.

Parks, D.H., Tyson, G.W., Hugenholtz, P., Beiko, R.G., 2014. STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics 30 (21), 3123–3124. https:// doi.org/10.1093/bioinformatics/btu494.

Pedersen, H.K., Gudmundsdottir, V., Nielsen, H.B., Hyotylainen, T., Nielsen, T., Jensen, B.A.H., Forslund, K., Hildebrand, F., Prifti, E., Falony, G.O., 2016. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535 (7612), 376–381. https://doi.org/10.1038/nature18646.

Pingitore, A., Chambers, E.S., Hill, T., Maldonado, I.R., Liu, B., Bewick, G., Morrison, D. J., Preston, T., Wallis, G.A., Tedford, C., Casta˜nera Gonz´alez, R., Huang, G.C., Choudhary, P., Frost, G., Persaud, S.J., 2017. The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. Diabetes Obes. Metabol. 19 (2), 257–265. https://doi. org/10.1111/dom.12811.

Raffaele, P., Adam, G.T., Kamlesh, K., Jonathan, V., Azeem, M., Christopher, M., Eszter, P.V., 2020. Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes. BMJ Open Diabetes Research & Care 8 (1), e001061. https://doi.org/10.1136/bmjdrc-2019-001061.

Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., Huttenhower, C., 2011. Metagenomic biomarker discovery and explanation. Genome Biol. 12 (6), R60. https://doi.org/10.1186/gb-2011-12-6-r60.

Sune, M.P., Sune, M., Sune, P., Dhok, A., Sune, M.P., 2023. Prevalence of retinopathy in prediabetic populations: a systematic review and meta-analysis. Cureus 15 (11). https://doi.org/10.7759/cureus.49602.

Tab´ak, A.G., Herder, C., Rathmann, W., Brunner, E.J., Kivim¨aki, M., 2012. Prediabetes: a high-risk state for diabetes development. Lancet 379 (9833), 2279–2290. https:// doi.org/10.1016/S0140-6736(12)60283-9.

Takeuchi, T., Kubota, T., Nakanishi, Y., Tsugawa, H., Suda, W., Kwon, A.T.-J., Yazaki, J., Ikeda, K., Nemoto, S., Mochizuki, Y., Kitami, T., Yugi, K., Mizuno, Y., 2023. Gut microbial carbohydrate metabolism contributes to insulin resistance. Nature 621 (7978), 389–395. https://doi.org/10.1038/s41586-023-06466-x.

Tong, A., Li, Z., Liu, X., Ge, X., Zhao, R., Liu, B., Zhao, L., Zhao, C., 2024. Laminaria japonica polysaccharide alleviates type 2 diabetes by regulating the microbiota-gut- liver axis: a multi-omics mechanistic analysis. Int. J. Biol. Macromol. 258, 128853. https://doi.org/10.1016/j.ijbiomac.2023.128853.

Tucker, J., Salas, J., Secrest, S., Scherrer, J.F., 2023. Erectile dysfunction associated with undiagnosed prediabetes and type 2 diabetes in young adult males: a retrospective cohort study. Prev. Med. 174, 107646. https://doi.org/10.1016/j. ypmed.2023.107646.

Valdivia-Garcia, M.A., Chappell, K.E., Camuzeaux, S., Olmo-García, L., van der Sluis, V. H., Radhakrishnan, S.T., Stephens, H., Bouri, S., de Campos Braz, L.M., Williams, H. T., 2022. Improved quantitation of short-chain carboxylic acids in human biofluids using 3-nitrophenylhydrazine derivatization and liquid chromatography with tandem mass spectrometry (LC-MS/MS). J. Pharmaceut. Biomed. Anal. 221, 115060. https://doi.org/10.1016/j.jpba.2022.115060.

Wang, C., Liu, Y., Chen, X., Zhu, J., Wu, Q., Chen, H., Liao, H., Lin, J., Wang, Z., Zheng, Z. J.S., Breathing, 2023. Meta-analysis of correlation between sleep duration and gender difference in adults with type 2 diabetes. Sleep Breath. 27 (6), 1–8. https:// doi.org/10.1007/s11325-023-02841-0.

Wang, K., Zhang, Z., Hang, J., Liu, J., Guo, F., Ding, Y., Li, M., Nie, Q., Lin, J., Zhuo, Y., Sun, L., Luo, X., Zhong, Q., Ye, C., Yun, C., Zhang, Y., Wang, J., Bao, R., Pang, Y., Wang, G., 2023. Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target. Science 381 (6657), eadd5787. https://doi.org/ 10.1126/science.add5787.

World Health Organization, 2006. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. https://www.who. int/publications/i/item/definition-and-diagnosis-of-diabetes-mellit us-and-intermediate-hyperglycaemia. (Accessed 16 July 2024).

Wu, J.-S., Yang, Y.-C., Lin, T.-S., Huang, Y.-H., Chen, J.-J., Lu, F.-H., Wu, C.-H., Chang, C.-J., 2007. Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. J. Clin. Endocrinol. Metabol. 92 (10), 3885–3889. https://doi.org/10.1210/jc.2006- 2175.

Wu, H., Tremaroli, V., Schmidt, C., Lundqvist, A., Olsson, L.M., Kr¨amer, M., Gummesson, A., Perkins, R., Bergstr¨om, G., B¨ackhed, F., 2020. The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study. Cell Metab. 32 (3), 379–390e373. https://doi.org/10.1016/j.cmet.2020.06.011.

Zeng, Y., Zhang, Z., Liang, S., Chang, X., Qin, R., Chen, H., Guo, L., 2023. Paternal sleep deprivation induces metabolic perturbations in male offspring via altered LRP5 DNA methylation of pancreatic islets. J. Pineal Res. 74 (4), e12863. https://doi.org/ 10.1111/jpi.12863.

Zhong, H., Ren, H., Lu, Y., Fang, C., Hou, G., Yang, Z., Chen, B., Yang, F., Zhao, Y., Shi, Z. J.E., 2019. Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics. EBioMedicine 47, 373–383 h ttps://doi.org/ 0.1016/j.ebiom.2019.08.048.

Zhou, W., Sailani, M.R., Contrepois, K., Zhou, Y., Ahadi, S., Leopold, S.R., Zhang, M.J., Rao, V., Avina, M., Mishra, T., Johnson, J., 2019. Longitudinal multi-omics of host–microbe dynamics in prediabetes. Nature 569 (7758), 663–671. https://doi. org/10.1038/s41586-019-1236-x.

Tools

CORE (COnnecting REpositories)

The University of West London

Fermented beetroot modulates gut microbial carbohydrate metabolism in prediabetes and prevents high-fat diet induced hyperglycemia in a prediabetic model

Abstract

Downloads

Actions (login required)

Menu